Results 151 to 160 of about 31,246 (217)

Attenuation of <i>Clostridioides difficile</i> Infection by <i>Clostridium hylemonae</i>. [PDF]

J Microbiol Biotechnol
Choi S, Kwon H, Kim WK, Ko G.
europepmc   +1 more source

Diagnostic challenges and treatment approaches for <i>Clostridioides difficile</i> infection in IBD patients. [PDF]

Front Microbiol
Ali A, AlHussaini KI.
europepmc   +1 more source

Microbiome Therapeutics for Clostridioides difficile Infection. [PDF]

Infect Dis Clin North Am
Lucky CW, Medernach RL, Kelly BJ, Kwon JH, Woodworth MH.   +4 more
europepmc   +1 more source

Initial Vancomycin Taper for the Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial.

JAMA Netw Open
McDonald EG, Butler-Laporte G, Brophy JM, Elsayed S, Frenette C, Huseen I, Loo VG, Moran K, Coburn B, Hota SS, Longtin Y, Kong LY, Muller MP, Steiner TS, Valiquette L, Daneman N, Daley P, Nott C, MacFadden DR, Kandel CE, Chen Y, Perez-Patrigeon S, Lee TC, TAPER-V Team.   +23 more
europepmc   +1 more source

Screening and targeted prophylaxis for Clostridioides difficile infection. [PDF]

Clin Microbiol Infect
Ziegler MJ, Anesi J, Tolomeo P, Glaser L, Cowden L, Cressman L, Huang E, Patel A, Lautenbach E, Pegues DA, Kelly BJ.   +10 more
europepmc   +1 more source

The Gut Microbiome and Butyrate Differentiate Clostridioides difficile Colonization and Infection in Children. [PDF]

J Infect Dis
Nicholson MR, Ma S, Strickland BA, Cecala M, Zhang L, Reasoner S, Guiberson ER, Munneke MJ, Shilts MH, Skaar EP, Das SR.   +10 more
europepmc   +1 more source